Spots Global Cancer Trial Database for hematological disease
Every month we try and update this database with for hematological disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| URMC Related Haplo-identical Donor BMT | NCT02660281 | Hematological D... Immune Deficien... Solid Tumors Myelofibrosis Multiple Myelom... Lymphoma | Total Body Irra... Fludarabine Pre-Stem Cell I... Pre-Stem Cell I... Busulfan Melphalan Stem Cell Infus... Post-Stem Cell ... Post-Stem Cell ... Thiotepa | 6 Months - 75 Years | University of Rochester | |
| URMC Related Haplo-identical Donor BMT | NCT02660281 | Hematological D... Immune Deficien... Solid Tumors Myelofibrosis Multiple Myelom... Lymphoma | Total Body Irra... Fludarabine Pre-Stem Cell I... Pre-Stem Cell I... Busulfan Melphalan Stem Cell Infus... Post-Stem Cell ... Post-Stem Cell ... Thiotepa | 6 Months - 75 Years | University of Rochester | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cord Blood Transplantation for Patients With Cancer | NCT01359254 | Hematological D... | Melphalan Fludarabine Antithymocyte G... Busulfan Total Body Irra... | 18 Years - | University of Chicago | |
| Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies | NCT00820508 | Hematological D... Lymphoid Malign... | CHR-2845 | 18 Years - | Chroma Therapeutics | |
| GENOMED4ALL: Improving MDS Classification and Prognosis by AI | NCT04889729 | Myelodysplastic... | 18 Years - | Istituto Clinico Humanitas | ||
| Exercise Following Autologous Peripheral Blood Stem Cell Transplantation | NCT00883961 | Hematological D... | Supervised exer... | 18 Years - 70 Years | Charite University, Berlin, Germany | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cord Blood Transplantation for Patients With Cancer | NCT01359254 | Hematological D... | Melphalan Fludarabine Antithymocyte G... Busulfan Total Body Irra... | 18 Years - | University of Chicago | |
| A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia | NCT00866762 | Polycythemia Ve... Essential Throm... | HDAC inhibitor ... | 18 Years - | Copenhagen University Hospital at Herlev | |
| Exercise Following Autologous Peripheral Blood Stem Cell Transplantation | NCT00883961 | Hematological D... | Supervised exer... | 18 Years - 70 Years | Charite University, Berlin, Germany | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| GENOMED4ALL: Improving MDS Classification and Prognosis by AI | NCT04889729 | Myelodysplastic... | 18 Years - | Istituto Clinico Humanitas |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
